NCT00003972View on ClinicalTrials.gov

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

DRUG

busulfan

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

melphalan

DRUG

paclitaxel

DRUG

tamoxifen citrate

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00003972 - Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer | Biotech Hunter | Biotech Hunter